Valuation
- Market cap
- 1,444,000
- Revenue TTM
- $1,860,000
- Net income TTM
- $-70,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -3.76%
- Debt to equity
- -0.03
Trading
- Volume
- 1,000
- Avg volume
- 25,218
- Day's range
- $0.04 – $0.04
- Shares out
- 33,424,000
- Stochastic %K
- 33%
- Beta
- -0.54
- Analysts
- Strong Buy
- Price target
- —
Company profile
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based...
Show more
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 561 558 2020
- Website
- https://www.vycormedical.com
- Address
- 951 Broken Sound Boulevard, Suite 320, Boca Raton, United States
Latest news
No headlines yet.
